Lab Automation Market: Regional Analysis and Growth Trends https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html The global lab automation market is projected to reach USD 7.1 billion by 2028 from USD 5.1 billion in 2022, growing at a CAGR of 5.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in lab automation, rise in demand for miniaturize process equipment further supports the market growth. However, higher initial investment impedes the market growth. However, the slow adoption of lab automation by some laboratories and the long waiting period for workflow implementation are expected to restrain the market growth.

Unlocking the Potential of Antibody Drug Conjugates: Market Insights and Innovations https://www.marketsandmarkets.com/Market-Reports/antibody-drug-conjugates-market-122857391.html The antibody drug conjugates market is projected to reach USD 19.8 Billion by 2028 from USD 9.7 Billion in 2023, at a CAGR of 15.2% during the forecast period. Growth in the antibody drug conjugates market can be attributed to factors such as the collaborations and partnerships among market players for the development of new ADCs, and the rising number of government approvals for antibody drug conjugates. The global antibody drug conjugates market is highly competitive. The prominent players operating in this market include F. Hoffmann-La Roche Ltd (Switzerland), Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), Astellas Pharma Inc (Japan), AstraZeneca (UK), ADC Therapeutics SA (Switzerland), ImmunoGen, Inc. (US), and Zydus Group (India), among others.

Strategies and Growth Opportunities in the Blood Group Typing Market https://www.marketsandmarkets.com/Market-Reports/blood-group-typing-market-72074095.html The blood group typing market is valued at an estimated USD 2.0 billion in 2023 and is projected to reach USD 3.0 billion by 2028 at a CAGR of 8.7% during the forecast period. Market growth is largely driven by the increasing prevalence of chronic diseases and the rising number of surgical procedures necessitating the need for blood donations. The key players in this market are Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (US), Grifols, S.A. (Spain), Thermo Fisher Scientific Inc. (US), Immucor, Inc. (US), Danaher (US), Merck KGaA (Germany), Quotient Limited (Switzerland), Novacyt (France), BAG Health Care GmbH (Germany), Rapid Labs Ltd (UK), Agena Bioscience, Inc. (US), Biorex Diagnostics (UK), HUMAN Gesellschaft für Biochemica und Diagnostica mbH (Germany), Prestige Diagnostics (UK), Span Diagnostics SARL (France), DIALAB GmbH (Austria), Lorne Laboratories Limited (UK), Atlas Medical GmbH (Germany), Torax Biosciences Limited (Northern Ireland), Fortress Diagnostics (UK), AXO Science (France), Maxwin Health Care Pvt. Ltd. (India), Anamol Laboratories Pvt. Ltd. (India), J. Mitra & Co. Pvt. Ltd. (India), and MedSource Ozone Biomedicals Pvt. Ltd. (India).

Market Dynamics of Endoscopy Equipment: Growth Drivers, Challenges, and Future Prospects https://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html The global endoscopy equipment market is projected to reach USD 40.6 billion by 2027 from USD 28.9 billion in 2022, at a CAGR of 7.0%. Endoscopy procedures are minimally invasive procedures wherein endoscopy instruments and supplies are used to examine a patient’s internal organ or tissue in detail. While conducting endoscopy, various tools and equipment, such as procedure-specific scopes, anesthetic equipment, video monitors, light sources, imaging devices, monitoring equipment, endoscope cabinets, video processors, insufflators, endoscopy cart, are used to ensure a safe procedure. Endoscopy equipment are primarily used by gastroenterologist, cardiologist, nephrologist, neurologist, hepatologist, and gynecologist.

Exploring Applications and Benefits of Negative Pressure Wound Therapy (NPWT) Solutions https://www.marketsandmarkets.com/Market-Reports/negative-pressure-wound-therapy-market-215139824.html The global NPWT devices market is projected to reach USD 3.2 billion by 2025 from USD 2.4 billion in 2020, at a CAGR of 6.1%. The rising prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and the high rate of cesarean sections in elderly mothers are the major factors driving the growth of the NPWT devices market. Also, emerging markets and the increasing sale of disposables and single-use consumables, are expected to offer growth opportunities for players operating in the NPWT devices market. The prominent players in the NPWT devices market are Acelity L.P. Inc. (US), Smith & Nephew (UK), Mölnlycke Healthcare AB (Sweden), ConvaTec Group Plc (UK), Cardinal Health (US), Paul Hartmann AG (Germany), DeRoyal (US), Lohmann & Rauscher International GmbH & Co KG. (Germany), Medela LLC (Switzerland), Genadyne Biotechnologies, Inc. (US), Triage Meditech Pvt. Ltd. (Delhi), Talley Group (UK), Alleva Medical Ltd. (China), Cork Medical (US), 4L Health Co. Ltd. (China), Carilex Medical GmbH (Germany), ChongQing Sunshine Medical Industry & Trading Co (China), Wuhan VSD Medical Science & Technology Co. Ltd. (China), Pensar Medical (US), and Haromed Bvba (Belgium).